Skip to content

Changes

View changes from to


On January 8, 2025 at 8:12:49 AM UTC, Gravatar Sitti Salmiah:
  • Updated description of Prevalence of malaria patients receiving 3-days ACT + 1-day Primaquine treatment from

    ###Definition: * Percentage of malaria patients receiving 3-days ACT (Artemisinin Combination Treatment) + 1-day Primaquine treatment. ###Unit of Measure: * Percent (%) ###Year: * 2023 ###SDG Indicator: * __3.3__ By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases ###CPAP Outcome: * Child Survival and Development ###CPAP Output: * EPI/Malaria/HIV
    to
    ###Definition: * Percentage of malaria patients receiving 3-days ACT (Artemisinin Combination Treatment) + 1-day Primaquine treatment. * 3-days ACT + 1-day Primaquine treatment is the standard treatment for malaria patients caused by _Plasmodium palcifarum_. ###Unit of Measure: * Percent (%) ###Year: * 2023 ###SDG Indicator: * __3.3__ By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases ###CPAP Outcome: * Child Survival and Development ###CPAP Output: * EPI/Malaria/HIV